Clinical Significance of Philadelphia-like-related Genes in a Resource-constrained Setting of Adult B-acute Lymphoblastic Leukemia Patients
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Roberts K
. The biology of Philadelphia chromosome-like ALL. Best Pract Res Clin Haematol. 2017; 30(3):212-221.
DOI: 10.1016/j.beha.2017.07.003.
View
2.
Gestrich C, De Lancy S, Kresak A, Meyerson H, Pateva I, Yalley A
. IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemia. Br J Haematol. 2023; 204(1):229-239.
DOI: 10.1111/bjh.19142.
View
3.
den Boer M, van Slegtenhorst M, de Menezes R, Cheok M, Buijs-Gladdines J, Peters S
. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2):125-34.
PMC: 2707020.
DOI: 10.1016/S1470-2045(08)70339-5.
View
4.
Gupta D, Varma N, Kumar A, Naseem S, Sachdeva M, Binota J
. PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of -like acute lymphoblastic leukaemia in Indian patients. Leuk Lymphoma. 2021; 63(3):633-643.
DOI: 10.1080/10428194.2021.1999439.
View
5.
Biondi A, Schrappe M, De Lorenzo P, Castor A, Lucchini G, Gandemer V
. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. Lancet Oncol. 2012; 13(9):936-45.
PMC: 3431502.
DOI: 10.1016/S1470-2045(12)70377-7.
View